An Analytical Quality by Design-guided method development for the quantification of N-nitroso-fluoxetine to support mitigation strategies for a fluoxetine drug product

Journal of Pharmaceutical and Biomedical Analysis · Published 2026-08-01 · DOI 10.1016/j.jpba.2026.117692

Authors (6)

Yue Zhang, Pierre-Yves Sacré, Bruno Streel, Eric Ziemons, Philippe Hubert, Cédric Hubert

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Zhang, Y., Sacré, P., Streel, B., et al. (2026). An Analytical Quality by Design-guided method development for the quantification of N-nitroso-fluoxetine to support mitigation strategies for a fluoxetine drug product. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2026.117692

Related articles

• Rapid quality evaluation of MXQLM based on bionic sensory and mathematical separation · Journal of Pharmaceutical and Biomedical Analysis · 2026 · Same journal
• Identification of related substances in baloxavir marboxil using 2D-LC-Q-TOF/MS · Journal of Pharmaceutical and Biomedical Analysis · 2026 · Same journal
• Biomimetic chromatographic descriptors for modeling therapeutic, toxic, and lethal blood concentration endpoints: convergence with conventional physicochemical properties · Journal of Pharmaceutical and Biomedical Analysis · 2026 · Same journal
• Optimization and clinical validation of a simplified workflow for renin-angiotensin-aldosterone system hormones and adrenal steroids: Addressing pre-analytical variability and operational efficiency · Journal of Pharmaceutical and Biomedical Analysis · 2026 · Same journal
• Differential impedimetric sensing of arboviruses using a lectin-modified hybrid polypyrrole-gold nanoparticle platform · Journal of Pharmaceutical and Biomedical Analysis · 2026 · Same journal
• Oxidative degradation of melatonin in solution and solid-state pharmaceutical blends: HPLC-HRMS/MS degradant characterization, metal-mediated acceleration and EDTA mitigation · Journal of Pharmaceutical and Biomedical Analysis · 2026 · Same journal
• Decoding thermal instability in peptide therapeutics links microheterogeneity to bioactivity loss · Journal of Pharmaceutical and Biomedical Analysis · 2026 · Same journal
• Solvent compatibility for extractables analysis of silicones · Journal of Pharmaceutical and Biomedical Analysis · 2026 · Same journal
• A chemiluminescence immunosensor for the detection of erythrocyte folate using specific monoclonal antibodies · Journal of Pharmaceutical and Biomedical Analysis · 2026 · Same journal
• Biosensing technologies for cannabinoid monitoring in pain management: Current methods, clinical needs, and translational challenges · Journal of Pharmaceutical and Biomedical Analysis · 2026 · Same journal